Consistently, by either intravenous injection of GFP+ MSCs (sorted from bone marrow of Nestin-GFP mice) to the CRE-treated mice, or directly immunizing Nestin-GFP mice with CRE, we observed significantly increased accumulation of GFP+ MSCs in the asthma airways. The gene discussed is NES; the disease is asthma.